PCFC

(redirected from Placebo-Controlled Food Challenge)
AcronymDefinition
PCFCPacking Credit in Foreign Currency (India)
PCFCPolytechnics and Colleges Funding Council
PCFCPressure Compensated Flow Control (valve; mechanical engineering)
PCFCPacific Coast Feather Company
PCFCPlacebo-Controlled Food Challenge (allergy management/immunology)
PCFCPolitical Contributions, Fees and Commissions
PCFCParsons Child and Family Center (Albany, NY)
PCFCPost-Compaction Fault Coverage
References in periodicals archive ?
After approximately one year of treatment, patients completed an exit double-blind, placebo-controlled food challenge.
The Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children Age 4-17 Years, or RAMSES (ARC007), trial is designed to gain experience with AR101 in a real-world setting, without the use of a double-blind, placebo-controlled food challenge (DBPCFC) to confirm peanut allergy.
studied the impact of wheat allergy in 179 adults with atopic eczema (128 females, 51 males; average age 26 years), using open exposure and double-blind, placebo-controlled food challenge tests, as well as specific serum IgE, skin prick, and atopy patch tests.
Following approximately 22 weeks of up-dosing, these patients were administered a double-blind, placebo-controlled food challenge (DBPCFC) to assess their levels of desensitization to peanut protein, with a maximum challenge dose of 600 mg (1,043 mg cumulative) of peanut protein.
Bock SA, Sampson HA, Atkins FM, et al Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual.
Possible cases of food allergy were investigated further with diagnosis made by double-blind, placebo-controlled food challenge (DBPCFC).
The second part of the study was a five-day double-blind placebo-controlled food challenge for cow's milk.
The double-blind placebo-controlled food challenge (DBPCFC) is still the gold standard for the diagnosis of food allergy; all allergy guidelines emphasise its importance and encourage its use.
Under the conditions of the study, skin test reagents from two companies showed slightly better agreement with double-blind, placebo-controlled food challenge results than did reagents from the third company.
The studies cited above all reported improved behavior ratings both during the OAD period (Phase 1) as well as during the placebo-controlled food challenge (Phase 3).
Double-blind, placebo-controlled food challenge is considered the standard in food allergy diagnosis.
Hence, studies using these biomarkers ideally require confirmation of allergy with double-blind, placebo-controlled food challenge trials.